Bristol Myers Squibb’s new multibillion-dollar partnership in a hot area of cancer research overshadowed many of the announcements at the recent annual meeting of the American Society of Clinical Oncology in Chicago. We covered that news and other developments from the largest cancer conference in the world.
The post ASCO 2025 Recap: Rise of the Bispecifics, Dueling Degraders, ADCs of Interest & More appeared first on MedCity News.
